Ignite Creation Date:
2025-12-25 @ 1:04 AM
Ignite Modification Date:
2025-12-25 @ 11:17 PM
Study NCT ID:
NCT01824693
Status:
COMPLETED
Last Update Posted:
2018-12-05
First Post:
2013-04-02
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia
Sponsor:
Children's Oncology Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-06-24
Start Date Type:
ACTUAL
Primary Completion Date:
2017-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2013-04-02
First Submit QC Date:
None
Study First Post Date:
2013-04-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-10-09
Results First Submit QC Date:
None
Results First Post Date:
2018-12-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-11-09
Last Update Post Date:
2018-12-05
Last Update Post Date Type:
ACTUAL